SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Ingredients: Top Headlines

Johnson Matthey posts higher Q3 API profits; Pfizer patent spat continues

Johnson Matthey sees anti-addiction APIs grown in Q3

28-Jan-2015 - Johnson Matthey saw demand for ADHD APIs increase in the third quarter, while sales of its pain management ingredients and bulk opiates declined.

Related news

News in brief

China patent gives Provectus green light to find partner for melanoma candidate, PV-10

27-Jan-2015 - China has told Provectus Biopharmaceuticals it will grant a patent for the method used to make the API in its skin cancer drug candidate, PV-10.

BASF to take on Asian PVP producers and target generics firms with new capacity in China

23-Jan-2015 - BASF will spend €56m to increase production capacity for the excipient PVP by expanding existing plants and introducing manufacturing capabilities at its facility in Shanghai, China.

Lonza benefits from outsourcing growth as Swiss franc fluctuations stall 2015 projections

22-Jan-2015 - Biopharma outsourcing growth has helped to boost the bottom line of Lonza, the world’s largest manufacturer of drug ingredients, though a topsy-turvy Swiss franc has caused the company to hold off on making any projections for 2015.

Insulin in sea snail venom could be used by drug developers

20-Jan-2015 - Sea snail venom could yield new human insulin analogues or painkillers, according to a University of Utah scientist.

USP pushes back deadline for elemental impurities compliance to 2018

20-Jan-2015 - In order to align more closely with ICH’s Q3D guideline for elemental impurities, USP has pushed back until 2018 when its chapter on elemental impurities will apply to industry.

Bile duct cancer breakthrough will not stretch paclitaxel supplies says analyst

14-Jan-2015 - Synthetic paclitaxel production methods can support expanding market and new indications according to market analysis group.

Resistance is…years away: New compound could delay post antibiotic era

08-Jan-2015 - Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape involved advanced chemistry according to the scientists who determined its structure.

Ingredients: Featured news

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social...

Resistance is…years away: New compound could delay post antibiotic era

Resistance is…years away: New compound could delay post antibiotic era

Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape...

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk...

Gilead strikes back at AbbVie with exclusive payer deal for hep C drug

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of...

Not prepared for track & trace? US FDA grants amnesty until May

Not prepared for track & trace? US FDA grants amnesty until May

The US FDA will give drugmakers and distributors until May to comply with new track and trace...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...